<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://wikimd.com/index.php?action=history&amp;feed=atom&amp;title=Mecasermin</id>
	<title>Mecasermin - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://wikimd.com/index.php?action=history&amp;feed=atom&amp;title=Mecasermin"/>
	<link rel="alternate" type="text/html" href="https://wikimd.com/index.php?title=Mecasermin&amp;action=history"/>
	<updated>2026-04-22T23:34:48Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.44.2</generator>
	<entry>
		<id>https://wikimd.com/index.php?title=Mecasermin&amp;diff=5339240&amp;oldid=prev</id>
		<title>Prab: CSV import</title>
		<link rel="alternate" type="text/html" href="https://wikimd.com/index.php?title=Mecasermin&amp;diff=5339240&amp;oldid=prev"/>
		<updated>2024-03-02T02:03:03Z</updated>

		<summary type="html">&lt;p&gt;CSV import&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;&amp;#039;&amp;#039;&amp;#039;Mecasermin&amp;#039;&amp;#039;&amp;#039; is a synthetic form of [[insulin-like growth factor 1]] (IGF-1), a hormone that stimulates growth in the body. It is used to treat growth failure in children with severe primary IGF-1 deficiency or with [[growth hormone]] (GH) gene deletion who have developed neutralizing antibodies to growth hormone.&lt;br /&gt;
&lt;br /&gt;
==Medical Uses==&lt;br /&gt;
Mecasermin is used to treat growth failure in children with severe primary IGF-1 deficiency or with growth hormone gene deletion who have developed neutralizing antibodies to growth hormone. It is not used for growth hormone deficiency, [[malnutrition]], [[hypothyroidism]], or long-term treatment of pediatric patients with growth failure due to genetically confirmed [[Prader-Willi syndrome]].&lt;br /&gt;
&lt;br /&gt;
==Pharmacology==&lt;br /&gt;
Mecasermin is a recombinant DNA-derived drug that is identical in sequence to naturally occurring human insulin-like growth factor-1. It binds to the [[IGF-1 receptor]] which is present on many cell types in many tissues. This binding promotes cell growth and multiplication, as well as cell survival.&lt;br /&gt;
&lt;br /&gt;
==Side Effects==&lt;br /&gt;
Common side effects of mecasermin include [[hypoglycemia]], injection site reactions, [[lipohypertrophy]], tonsillar hypertrophy, and [[snoring]]. Serious side effects may include [[hypoglycemia]], [[intracranial hypertension]], and [[allergic reactions]].&lt;br /&gt;
&lt;br /&gt;
==History==&lt;br /&gt;
Mecasermin was approved for medical use in the United States in 2005. It is marketed under the brand name Increlex by [[Ipsen]].&lt;br /&gt;
&lt;br /&gt;
==See Also==&lt;br /&gt;
* [[Insulin-like growth factor 1]]&lt;br /&gt;
* [[Growth hormone]]&lt;br /&gt;
* [[Prader-Willi syndrome]]&lt;br /&gt;
&lt;br /&gt;
[[Category:Drugs]]&lt;br /&gt;
[[Category:Endocrinology]]&lt;br /&gt;
[[Category:Pediatrics]]&lt;br /&gt;
{{Pharma-stub}}&lt;br /&gt;
{{Medicine-stub}}&lt;/div&gt;</summary>
		<author><name>Prab</name></author>
	</entry>
</feed>